Treatment-induced amenorrhoea for patients with HER2-positive early breast cancer: Does it matter?

Giuseppe Gullo; Jack P. Gleeson

doi:10.21037/tcr.2018.09.06

Treatment-induced amenorrhoea for patients with HER2-positive early breast cancer: Does it matter?

Giuseppe Gullo
, Jack P. Gleeson

University College Dublin

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	1357-1360
Number of pages	4
Journal	Translational Cancer Research
Volume	7
Issue number	6
DOIs	https://doi.org/10.21037/tcr.2018.09.06
Publication status	Published - 1 Dec 2018
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.21037/tcr.2018.09.06

Cite this

@article{079469c5fa33451caf26130e5f6daad7,

title = "Treatment-induced amenorrhoea for patients with HER2-positive early breast cancer: Does it matter?",

author = "Giuseppe Gullo and Gleeson, \{Jack P.\}",

year = "2018",

month = dec,

day = "1",

doi = "10.21037/tcr.2018.09.06",

language = "English",

volume = "7",

pages = "1357--1360",

journal = "Translational Cancer Research",

issn = "2218-676X",

publisher = "AME Publishing Company",

number = "6",

}

TY - JOUR

T1 - Treatment-induced amenorrhoea for patients with HER2-positive early breast cancer

T2 - Does it matter?

AU - Gullo, Giuseppe

AU - Gleeson, Jack P.

PY - 2018/12/1

Y1 - 2018/12/1

UR - https://www.scopus.com/pages/publications/85059359226

U2 - 10.21037/tcr.2018.09.06

DO - 10.21037/tcr.2018.09.06

M3 - Review article

AN - SCOPUS:85059359226

SN - 2218-676X

VL - 7

SP - 1357

EP - 1360

JO - Translational Cancer Research

JF - Translational Cancer Research

IS - 6

ER -

Treatment-induced amenorrhoea for patients with HER2-positive early breast cancer: Does it matter?

UN SDGs

Access to Document

Other files and links

Cite this